We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Ultra-Rare Set of Blood Groups Identified

By LabMedica International staff writers
Posted on 11 Oct 2022
Print article
Image: The mechanosensory ion channel Piezo1 is the carrier molecule for Er red cell antigens, establishing a new blood group system (Photo courtesy of University of Bristol)
Image: The mechanosensory ion channel Piezo1 is the carrier molecule for Er red cell antigens, establishing a new blood group system (Photo courtesy of University of Bristol)

The two primary blood group systems, the ABO and Rh- systems are known to the majority of individuals. There are other additional blood group systems, each with a unique range of reaction risk. Additionally, different blood group antigens exist within each blood group system.

Despite the identification of the high incidence red cell antigen Era nearly 40 years ago, the molecular background of this antigen, together with the other two members of the Er blood group collection, has yet to be elucidated. The mechanosensory ion channel Piezo1 is the carrier molecule for the Er red cell antigens, establishing a new blood group system.

A team of Transfusion Medicine Specialists led by those at the NHS Blood and Transplant, (Bristol, UK) performed Whole exome and Sanger sequencing of individuals with serologically defined Er alloantibodies and identified several missense mutations within the PIEZO1 gene, encoding amino acid substitutions within the extracellular domain of the Piezo1 mechanosensor ion channel. Confirmation of Piezo1 as the carrier molecule for the Er blood group antigens was demonstrated using immunoprecipitation, CRISPR/Cas9-mediated gene knockout and expression studies in an erythroblast cell line.

The team described the molecular bases of five Er blood group antigens. They recognized Era, Erb and Er3 antigens; and two novel high incidence Er antigens, described as Er4 and Er5, establishing a new blood group system. The clinical significance of antibodies against Er4 and Er5 is poorly understood due to a lack of data, but two cases of severe hemolytic disease of the fetus and newborn have been reported in women with these antibodies. Er was recognized as a blood group collection by the International Society of Blood Transfusion in 1990 and promoted to a blood group in 2022. Missense mutations in PIEZO1, encoding the Piezo1 mechanosensor protein, defines the Er red blood cell antigens.

Nicole M Thornton, PhD, Head of Red Cell Reference at NHSBT’s International Blood Group Reference Laboratory, said, “Most people will have what we consider to be the ‘regular’ form of Er but a small number of rare individuals have altered forms, including the new ones we identified in this study. Discovering the genetic basis of blood groups allows us to develop new tests to identify those with uncommon blood groups, with the aim of providing the best possible care for even the rarest of patients. The more we know about such rare blood group variations, along with the ability to be able to test for and identify them, the better care we are able to offer to such patients in the future.”

The authors concluded that demonstration of Piezo1, present at just a few hundred copies on the surface of the red blood cell, as the site of a new blood group system highlights the potential antigenicity of even low abundance membrane proteins and contributes to our understanding of the in vivo characteristics of this important and widely studied protein in transfusion biology and beyond. The study was published on September 19, 2022 in the journal Blood.

Related Links:
NHS Blood and Transplant

Platinum Supplier
Hormonal Test
Endocrine Array
New
Fecal Occult Blood Test
iFOB Assay
New
Chlamydia Infection Diagnostic Test
Chlamydia Test
New
Rapid Immunological FOB Test
Fecal Occult Blood Test

Print article
SUGENTECH INC.

Channels

Clinical Chem.

view channel
Image: ELISA kit for liver-type fatty acid–binding protein (L-FABP). The level of L-FABP present in urine reflects the level of renal tubular dysfunction (Photo courtesy of Sekisui Medical Co)

Urinary Biomarkers Predict Weaning From Acute Dialysis Therapy

Acute kidney injury is associated with a higher risk of chronic kidney disease (CKD), end-stage renal disease, and long-term adverse cardiovascular effects. Critically ill patients with acute kidney injury... Read more

Microbiology

view channel
Image: Ring-form trophozoites of Plasmodium vivax in a thin blood smear (Photo courtesy of Centers for Disease Control and Prevention)

Immune Regulators Predict Severity of Plasmodium vivax Malaria

Cytokines and chemokines are immune response molecules that display diverse functions, such as inflammation and immune regulation. In Plasmodium vivax infections, the uncontrolled production of these molecules... Read more

Pathology

view channel
Image: Breast cancer spread uncovered by new molecular microscopy (Photo courtesy of Wellcome Sanger Institute)

New Molecular Microscopy Tool Uncovers Breast Cancer Spread

Breast cancer commonly starts when cells start to grow uncontrollably, often due to mutations in the cells. Overtime the tumor becomes a patchwork of cells, called cancer clones, each with different mutations.... Read more

Industry

view channel
Image: With Cell IDx’s acquisition, Leica Biosystems will be moving its multiplexing menu forward (Photo courtesy of Leica Biosystems)

Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling

Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging (Nussloch, Germany), has acquired Cell IDx, Inc. (San Diego, CA, USA), which provides multiplex staining... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.